S.L.A. Pharma AG
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.slapharma.com
EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)
- Conditions
- SARS-CoV-2
- Interventions
- Drug: PlaceboDrug: Eicosapentaenoic acid gastro-resistant capsules
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 284
- Registration Number
- NCT04335032
- Locations
- 🇪🇸
Hospital Universitario Vall d'Hebron, Barcelona, Spain
🇬🇧Hull, Cottingham, United Kingdom
🇬🇧UHCW, Coventry, United Kingdom
Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 80
- Registration Number
- NCT04273997
- Locations
- 🇹🇷
Erzincan Binali Yıldırım University General Surgery Clinic, Erzincan, Turkey
🇹🇷Samsun Training and Research Hospital General Surgery Clinic, Samsun, Turkey
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
- Conditions
- Familial Adenomatous Polyposis
- Interventions
- Drug: Eicosapentaenoic acid free fatty acid (EPA-FFA)Drug: Placebo
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 204
- Registration Number
- NCT03806426
- Locations
- 🇮🇹
University of Bologna and St.Orsola-Malpighi Hospital, Bologna, Italy
Diltiazem Hydrochloride Cream for Anal Fissure
- Conditions
- Chronic Anal Fissure
- Interventions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 465
- Registration Number
- NCT01217515
- Locations
- 🇧🇬
Dr Kantcho Kostadinov, Sevileva, Sevilieva, Bulgaria
🇧🇬Vth MHAT, Sofia, Bulgaria
🇧🇬MHAT Alexandrovska EAD, Sofia, Bulgaria
Naloxone SR Capsules in Patients With Opioid Induced Constipation
- Conditions
- Chronic PainOpioid Induced Constipation
- Interventions
- First Posted Date
- 2009-09-25
- Last Posted Date
- 2013-12-27
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 40
- Registration Number
- NCT00984334
- Locations
- 🇩🇪
Schmerzzentrum Berlin, Berlin, Germany
🇩🇪Schmerzzentrum Frankfurt, Frankfurt, Germany
🇩🇪Gemeinschaftspraxis Tamm-Albert-Schroter-Uhmann, Hannover, Germany
Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 19
- Registration Number
- NCT00774969
- Locations
- 🇬🇧
Sainsbury Wing, St Marks & Northwick Park Hospitals, Watford Road, Harrow, United Kingdom
A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy
- First Posted Date
- 2008-10-17
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 59
- Registration Number
- NCT00774722
- Locations
- 🇬🇧
Royal Sussex County Hospital, Eastern Road,, Brighton, United Kingdom
🇬🇧St Marks Hospital, Harrow, United Kingdom
🇬🇧North Middlesex University Hospital, London, United Kingdom
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
- Conditions
- Familial Adenomatous Polyposis ColiFAP
- Interventions
- Drug: Eicosapentanoic Acid (EPA)Procedure: EndoscopyProcedure: Biopsies takenDrug: Placebo
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2014-08-22
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 58
- Registration Number
- NCT00510692
- Locations
- 🇬🇧
The Polyposis Registry, St. Mark's Hospital,, Harrow, Middlesex, United Kingdom
Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 74
- Registration Number
- NCT00509639
- Locations
- 🇺🇸
Washington University School of Medicine, St Louis, Missouri, United States
🇬🇧Derby City General Hospital, Derby, Derbyshire, United Kingdom
🇬🇧Leicester General Hospital, Leicester, Leicestershire, United Kingdom
Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
- Conditions
- Adenomatous Polyps
- Interventions
- Drug: Eicosapentaenoic Acid (EPA)Procedure: EndoscopyProcedure: Biopsies takenProcedure: Clinical chemistryProcedure: HaematologyProcedure: Physical examinationProcedure: Vital signsProcedure: Urine pregnancy testProcedure: Completion of patient diary card
- First Posted Date
- 2007-02-08
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- S.L.A. Pharma AG
- Target Recruit Count
- 120
- Registration Number
- NCT00432913
- Locations
- 🇮🇹
S. Orsola Hospital, Bologna, Italy
🇬🇧St. George's Hospital Medical School, London, United Kingdom